V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 160012722 | 160006135 | 1.84 | 60 | null | 2016-11-04 | 2016-11-05 | Cisplatin + Pemetrexed | 02 | null | CISPLATIN + PEMETREXED | 101146745 |
| 160012723 | 160006136 | 1.77 | 87.5 | Palliative (P) | 2017-06-04 | 2017-06-07 | CHOP | 02 | N | DACTINOMYCIN + IFOSFAMIDE + VINCRISTINE | 101022033 |
| 160012724 | 160006137 | null | 74.8 | Neo-adjuvant (N) | 2019-10-02 | 2019-10-02 | EW EuroEwing 2012 Arm A VIDE | 01 | null | DOXORUBICIN | 101370935 |
| 160012725 | 160006138 | 1.84 | 70 | Palliative (P) | 2018-03-04 | 2018-03-04 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 101649994 |
| 160012728 | 160006139 | null | null | Curative (C) | 2017-11-26 | 2017-11-26 | GemCarbo Days 1+8 | 02 | null | BORTEZOMIB | 101048057 |
| 160012730 | 160006140 | 1.67 | null | Palliative (P) | 2016-11-07 | 2016-11-21 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100639919 |
| 160012731 | 160006141 | null | null | null | 2017-10-24 | 2017-10-24 | Cisplatin + Pemetrexed | 02 | null | CISPLATIN + PEMETREXED | 100581829 |
| 160012732 | 160006142 | 0 | 10.3 | Palliative (P) | 2017-09-08 | 2017-09-08 | ATOMIC-MESO TRIAL | null | Y | DOXORUBICIN + IFOSFAMIDE | 100312361 |
| 160012734 | 160006143 | 1.65 | 70.9 | Curative (C) | 2018-02-09 | 2018-02-13 | Carboplatin AUC 2 - 5 | 02 | N | CARBOPLATIN | 101667900 |
| 160012736 | 160006144 | 0 | 0 | Palliative (P) | 2017-02-18 | 2017-02-18 | GEMCITABINE + PACLITAXEL ALBUMIN (ABRAXANE) | 02 | N | TRIAL UNSPECIFIED | 100799080 |
| 160012737 | 160006145 | 1.63 | 80.3 | Palliative (P) | 2018-09-14 | 2018-09-16 | Ifosfamide | 2 | N | DOXORUBICIN | 100004656 |
| 160012738 | 160006146 | null | null | Palliative (P) | 2017-02-02 | 2017-02-10 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100873965 |
| 160012739 | 160006147 | 1.73 | 62.75 | Palliative (P) | 2020-08-19 | 2020-08-29 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 101097281 |
| 160012741 | 160006148 | 1.57 | 58.5 | Palliative (P) | 2019-05-11 | 2019-05-11 | Vinorelbine (oral) | 1 | N | BLEOMYCIN + CISPLATIN + ETOPOSIDE | 100864993 |
| 160012742 | 160006149 | 1.75 | 64.6 | Curative (C) | 2016-03-11 | 2016-03-24 | Trial Unspecified | 02 | N | TRIAL UNSPECIFIED | 101104659 |
| 160012744 | 160006150 | 0 | 15.8 | Curative (C) | null | 2017-06-26 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100321461 |
| 160012745 | 160006151 | 1.61 | 75.3 | Neo-adjuvant (N) | 2018-10-27 | 2018-10-28 | DOXORUBICIN | 02 | N | MELPHALAN | 100131116 |
| 160012749 | 160006152 | 1.72 | 75.1 | null | null | 2016-10-13 | Cisplatin + Pemetrexed | null | null | CISPLATIN + PEMETREXED | 100354017 |
| 160012750 | 160006153 | 1.56 | 101 | null | 2018-05-17 | 2018-05-24 | Doxorubicin + Olaratumab | 02 | null | CARBOPLATIN | 100542139 |
| 160012751 | 160006154 | 1.53 | 47.9 | Palliative (P) | 2020-04-22 | 2020-04-22 | PACLITAXEL | 02 | N | DOXORUBICIN + IFOSFAMIDE | 100598613 |
| 160012756 | 160006156 | 1.51 | 65 | Palliative (P) | 2018-11-24 | 2018-11-29 | Cisplatin + Pemetrexed | 02 | null | CISPLATIN + PEMETREXED | 101416025 |
| 160012758 | 160006157 | 1.75 | 89.2 | null | 2016-03-29 | 2016-03-30 | CARBOPLATIN + GEMCITABINE | 02 | null | CISPLATIN + DOXORUBICIN | 100056677 |
| 160012759 | 160006158 | 1.75 | 59.8 | Neo-adjuvant (N) | 2018-12-03 | 2018-12-12 | Cisplatin + Pemetrexed | 01 | N | CISPLATIN + PEMETREXED | 101238281 |
| 160012760 | 160006159 | 1.83 | null | Palliative (P) | 2018-10-19 | 2018-11-01 | Cisplatin + Pemetrexed | null | N | CISPLATIN + PEMETREXED | 101447680 |
| 160012762 | 160006160 | 1.82 | 22 | null | 2017-01-03 | 2017-01-24 | null | 01 | N | TRIAL UNSPECIFIED | 100929788 |
| 160012763 | 160006161 | 1.73 | 79.3 | null | 2018-04-01 | 2018-04-15 | Trial Unspecified | 02 | null | TRIAL UNSPECIFIED | 100597755 |
| 160012764 | 160006162 | 1.76 | 61 | 03 | 2017-12-17 | 2017-12-18 | Carboplatin + Paclitaxel (weekly) | null | N | CARBOPLATIN + PACLITAXEL | 100767030 |
| 160012765 | 160006163 | 1.79 | 67.1 | null | null | 2017-04-09 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 02 | null | EW EUROEWING 2012 ARM A VIDE | 100451798 |
| 160012766 | 160006164 | 1.73 | 63.4 | Curative (C) | 2019-10-04 | 2019-10-04 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100439989 |
| 160012767 | 160006165 | 1.71 | 70 | Palliative (P) | 2016-06-14 | 2016-06-26 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 101547526 |
| 160012769 | 160006166 | 1.82 | 67.4 | Palliative (P) | 2019-03-30 | 2019-04-04 | Bevacizumab | N | N | DOXORUBICIN + OLARATUMAB | 100015520 |
| 160012770 | 160006167 | 1.67 | 80 | Palliative (P) | null | 2019-02-21 | Doxorubicin + Olaratumab | 02 | N | DOXORUBICIN + OLARATUMAB | 100377504 |
| 160012772 | 160006168 | 1.79 | 89.6 | Adjuvant (A) | 2017-04-01 | 2017-04-22 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100780784 |
| 160012773 | 160006169 | 1.58 | 133 | null | 2019-03-29 | 2019-04-25 | Doxorubicin + Olaratumab | 01 | N | DOXORUBICIN | 100309697 |
| 160012776 | 160006170 | 1.7 | 89.3 | Palliative (P) | 2019-05-30 | 2019-05-30 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 101680616 |
| 160012777 | 160006171 | 1.67 | 86.8 | Palliative (P) | 2018-07-02 | 2018-07-03 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 101767643 |
| 160012779 | 160006172 | 1.71 | 74.9 | null | 2016-05-31 | 2016-06-15 | Cisplatin + Pemetrexed | 02 | null | CISPLATIN + PEMETREXED | 100121424 |
| 160012781 | 160006173 | 1.72 | 79.1 | Palliative (P) | 2018-11-04 | 2018-11-04 | IVADo | 02 | N | TRABECTEDIN | 100075332 |
| 160012784 | 160006174 | 1.7 | 102.5 | Palliative (P) | 2016-11-01 | 2016-11-04 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100677359 |
| 160012785 | 160006175 | 1.7 | 69.9 | Palliative (P) | 2017-07-06 | 2017-07-23 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100590572 |
| 160012786 | 160006176 | 1.73 | 94 | null | null | 2017-08-16 | Liposomal Doxorubicin (Caelyx) | 01 | N | CRIZOTINIB | 101019418 |
| 160012788 | 160006177 | 1.85 | 75.65 | Palliative (P) | 2018-08-13 | 2018-08-23 | Trial Unspecified | 2 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + VINCRISTINE | 101242317 |
| 160012792 | 160006178 | 1.78 | 72.4 | Palliative (P) | 2016-11-11 | 2016-11-16 | Cisplatin + Pemetrexed | null | N | CISPLATIN + PEMETREXED | 100683764 |
| 160012797 | 160006179 | 1.81 | 69 | Neo-adjuvant (N) | 2017-10-29 | 2017-11-11 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100571399 |
| 160012798 | 160006180 | 1.52 | 73 | Neo-adjuvant (N) | 2017-03-13 | 2017-03-31 | Doxorubin 50mg/m2 | 02 | N | TRIAL UNSPECIFIED | 101660535 |
| 160012803 | 160006181 | 1.66 | 88 | null | 2016-06-10 | 2016-07-04 | null | 02 | null | DOXORUBICIN | 100449495 |
| 160012806 | 160006182 | 1.76 | 69 | Curative (C) | null | 2018-07-31 | Cisplatin + Pemetrexed | 01 | N | CISPLATIN + PEMETREXED | 100074039 |
| 160012808 | 160006183 | 1.84 | 71.5 | 03 | 2018-11-24 | 2018-11-24 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 101561389 |
| 160012809 | 160006184 | 1.75 | 62.2 | Neo-adjuvant (N) | 2016-06-09 | 2016-07-02 | IPM | 02 | N | IVADO | 100207402 |
| 160012810 | 160006185 | 0 | 55.6 | Palliative (P) | 2018-12-05 | 2018-12-12 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 101557948 |